Abstract

DRAM2-associated retinopathy is a rare inherited retinal dystrophy, and its outcome has not been determined. A single retinal involvement by a mutation of the DRAM2 gene is unexplained. We found three unrelated patients with a disease-causing DRAM2 variant in a biallelic state from 1555 Japanese individuals of 1314 families with inherited retinal dystrophy. We reviewed their medical records and examined their peripheral lymphocytes by transmission electron microscopy (TEM). Patient 1 was a 38-year-old woman who complained of night blindness and reduced vision. She developed macular degeneration at age 43 years. Patients 2 and 3 were a man and a woman both of whom noticed night blindness in their 30s. Both had a degeneration in the macula and midperiphery in their 40s, which progressed to a diffuse retinal degeneration in their 60s when their vision was reduced to hand motions. Three novel DRAM2 variants were identified. TEM of the lymphocytes of Patients 1 and 2 showed abnormal structures in 40.6% and 0.3% of the peripheral lymphocytes, respectively. We concluded that the DRAM2-associated retinopathy of our patients was a progressive rod-cone dystrophy, and the visual outcome was poor. The systemic effect of DRAM2 mutations may be compensable and have variations.

Highlights

  • DNA-damage regulated autophagy modulator 2 (DRAM2; MIM #613360; GenBank NM_178454.4) is known as transmembrane protein 77 (TMEM77)

  • The DRAM2 gene is located at locus 13.3 on the short arm of chromosome 1 and encodes a 266-amino acid transmembrane protein, which plays a role in autophagy induction [1,2] and tumor suppression [3]

  • This study aimed to determine the clinical course of three patients with DRAM2-associated retinopathy at an advanced stage of the retinopathy and to present the effects of the DRAM2 variants on the peripheral lymphocytes, determined by transmission electron microscopy (TEM)

Read more

Summary

Introduction

DNA-damage regulated autophagy modulator 2 (DRAM2; MIM #613360; GenBank NM_178454.4) is known as transmembrane protein 77 (TMEM77). An autosomal recessive cone-rod dystrophy with macular involvement is reported as DRAM2-associated retinopathy (CORD21) [5,6,7,8]. It is a rare inherited retinal dystrophy, and only 21 patients in 10 families have been reported [5,6,7,8]. The findings at the advanced stage of DRAM2-associated retinopathy have not been reported, and a single retinal involvement by a mutation of the DRAM2 gene is unexplained

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.